Research Tracker›Biomarker Atlas›PACVS›Wild-type viral spike peptides

Wild-type viral spike peptides in PACVS

Wild-type viral spike peptides, also described as Infection-derived spike, is a molecular marker reported as reduced in PACVS (PACVS, PCVS) when patients are compared with Vaccine-only individuals. Symptom domains tied to this marker in the source include indicates prior infection, not pure PACVS. The finding is drawn from Sutton et al. 2023; it describes group-level differences, not a threshold that classifies an individual.

↓ ReducedMolecular

Summary

Direction in PACVS↓ Reduced — lower than in the comparison group
CategoryMolecular
Also described asInfection-derived spike
Compared againstVaccine-only individuals
Associated symptomsIndicates prior infection, not pure PACVS
Test typeClinical or physiological test
SourceSutton et al. 2023 — doi:10.1016/j.vaccine.2023.04.044
Condition atlasPACVS Biomarker Atlas

Related Molecular markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is Wild-type viral spike peptides high or low in PACVS?

Reduced. Studies summarised in the OSMF atlas report lower Wild-type viral spike peptides in PACVS than in Vaccine-only individuals. Source: Sutton et al. 2023.

What symptoms is Wild-type viral spike peptides associated with in PACVS?

The cited literature associates this marker with Indicates prior infection, not pure PACVS. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Wild-type viral spike peptides?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Wild-type viral spike peptides result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. Wild-type viral spike peptides findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Wild-type viral spike peptides in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/wild-type-viral-spike-peptides.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.